Savvy Advisors Inc. Has $1.98 Million Stake in Stryker Corporation $SYK

Savvy Advisors Inc. increased its position in shares of Stryker Corporation (NYSE:SYK) by 81.2% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 5,630 shares of the medical technology company’s stock after acquiring an additional 2,523 shares during the period. Savvy Advisors Inc.’s holdings in Stryker were worth $1,979,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the company. Town & Country Bank & Trust CO dba First Bankers Trust CO boosted its stake in shares of Stryker by 40.9% during the fourth quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 14,213 shares of the medical technology company’s stock valued at $4,995,000 after purchasing an additional 4,124 shares in the last quarter. Maryland Capital Advisors Inc. grew its holdings in shares of Stryker by 26.7% during the fourth quarter. Maryland Capital Advisors Inc. now owns 171 shares of the medical technology company’s stock worth $60,000 after purchasing an additional 36 shares during the last quarter. Stratos Wealth Partners LTD. increased its stake in shares of Stryker by 3.1% in the fourth quarter. Stratos Wealth Partners LTD. now owns 19,599 shares of the medical technology company’s stock valued at $6,889,000 after buying an additional 598 shares during the period. Perpetual Ltd raised its holdings in Stryker by 32.5% in the 4th quarter. Perpetual Ltd now owns 1,981 shares of the medical technology company’s stock valued at $696,000 after buying an additional 486 shares during the last quarter. Finally, SOA Wealth Advisors LLC. raised its holdings in Stryker by 24.2% in the 4th quarter. SOA Wealth Advisors LLC. now owns 159 shares of the medical technology company’s stock valued at $56,000 after buying an additional 31 shares during the last quarter. 77.09% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, Director Ronda E. Stryker sold 250,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the sale, the director owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. This trade represents a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 5.90% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on SYK shares. Robert W. Baird set a $437.00 target price on shares of Stryker in a report on Friday, January 30th. William Blair reaffirmed an “outperform” rating on shares of Stryker in a research note on Thursday, March 5th. Jefferies Financial Group reiterated a “buy” rating and set a $465.00 price target on shares of Stryker in a report on Wednesday, March 4th. Citizens Jmp upgraded Stryker from a “market perform” rating to an “outperform” rating and set a $440.00 price objective for the company in a report on Friday, December 19th. Finally, TD Cowen lowered Stryker from a “buy” rating to a “hold” rating and set a $387.00 target price for the company. in a research report on Monday, January 26th. Fourteen equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $427.50.

Stryker Stock Performance

NYSE:SYK opened at $331.48 on Monday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.21 and a current ratio of 1.89. Stryker Corporation has a fifty-two week low of $319.32 and a fifty-two week high of $404.87. The company has a 50 day simple moving average of $357.10 and a two-hundred day simple moving average of $361.76. The company has a market capitalization of $126.95 billion, a PE ratio of 39.46, a P/E/G ratio of 1.94 and a beta of 0.92.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, beating analysts’ consensus estimates of $4.40 by $0.07. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The company had revenue of $7.17 billion for the quarter, compared to analyst estimates of $7.12 billion. During the same period in the prior year, the firm posted $4.01 EPS. The company’s quarterly revenue was up 11.4% on a year-over-year basis. Research analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. Stryker’s dividend payout ratio is 41.90%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.